exRNAdisease

Entry Detail

---



General Information

Database ID: exR0354228 RNA Name: hsa-miR-21-5p RNA Type: miRNA Chromosome: chr17 Starnd: + Coordinate: Start Site(bp): 59841273 End Site(bp): 59841294 External Links: hsa-miR-21-5p

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE93850 Description: Serum miRNAs in Patients with Glioblastoma Multiforme Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 22 Number of Control: 8 Number of Samples: 30

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand KAZN chr1 13892792 15118043 + UBE2T chr1 202331657 202341980 - CLEC2D chr12 9664969 9699553 + EIF4A2 chr3 186783205 186789897 + MGST1 chr12 16347142 16609259 + POLE3 chr9 113407235 113410675 - SOWAHC chr2 109614364 109618990 + OSER1 chr20 44195939 44210771 - EXOC4 chr7 133253073 134066589 + EDARADD chr1 236348257 236502915 + HNRNPA0 chr5 137745651 137754363 - GPSM3 chr6 32190766 32195523 - CTH chr1 70411218 70439851 + CITED2 chr6 139371807 139374648 - MTREX chr5 55307989 55425579 + AP3D1 chr19 2100988 2164468 - ELP2 chr18 36129444 36180557 + HSPA4 chr5 133052013 133106449 + RGS1 chr1 192575763 192580024 + HSD17B4 chr5 119452473 119637199 + ZFP36L1 chr14 68787660 68796253 - HMGA1 chr6 34236873 34246231 + EEF1B2 chr2 206159585 206162928 + DYNC1H1 chr14 101964573 102056443 + DUSP2 chr2 96143169 96145440 - MCRS1 chr12 49556544 49568145 - ATRX chrX 77504878 77786233 - ZADH2 chr18 75195113 75209139 - PLIN2 chr9 19108375 19149290 - TREX1 chr3 48465811 48467645 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001731 chr7 100731990 100738448 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC068768.1 chr12 123262060 123262402 + ARHGAP27P1-BPTFP1-KPNA2P3 chr17 64749663 64781707 - OTUD6B-AS1 chr8 91059318 91070583 - SNHG1 chr11 62851984 62855953 - TUG1 chr22 30969245 30979395 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE93850 Sample Source: Blood Source Fraction: Serum Platform: GPL22948 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1032 Sample treatment protocol: NA RNA Extract protocol: Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada) RNA library preparation protocol: 0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.

Reference

PMID: 28931080 Title: Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma Author: Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX Journal: PLoS One. 2017 Sep 20;12(9):e0184969. Description: we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.